首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >Selective modulation of noradrenaline release by α2-adrenoceptor blockade in the rat-tail artery in vitro
【2h】

Selective modulation of noradrenaline release by α2-adrenoceptor blockade in the rat-tail artery in vitro

机译:体外α2-肾上腺素受体阻断剂选择性调节去甲肾上腺素的释放

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

class="enumerated" style="list-style-type:decimal">The effects of blocking α2-adrenoceptors on noradrenaline (NA) and adenosine 5′-triphosphate (ATP) release from postganglionic sympathetic nerves have been investigated in rat-tail artery in vitro. Continuous amperometry was used to measure NA release and intracellularly recorded excitatory junction potentials (e.j.p.'s) were used to measure ATP release.Application of the α2-adrenoceptor antagonist, idazoxan (1 μM), increased the amplitude of NA-induced oxidation currents evoked by trains of 10 stimuli at 1 and 10 Hz.In cells deep in the media, idazoxan (1 μM) had no effect on the amplitude of e.j.p.'s evoked by trains of 10 stimuli at 1 and 10 Hz. In cells close to the adventitial – medial border, idazoxan produced a small increase in the amplitude of e.j.p.'s evoked at the end of trains of 10 stimuli at 1 Hz.In tissues pretreated with the neuronal NA uptake inhibitor, desmethylimpramine (0.3 μM), idazoxan (1 μM) markedly increased the amplitude of e.j.p.'s in cells deep in the media.The α2-adrenoceptor agonist, clonidine (0.5 μM), produced similar reductions in the amplitudes of both NA-induced oxidation currents and e.j.p.'s evoked by 10 stimuli at 1 Hz. These effects of clonidine were reversed by the subsequent addition of idazoxan (1 μM).The release of both NA and ATP is inhibited to a similar extent by activation of prejunctional α2-adrenoceptors by clonidine. In contrast, endogenously released NA more markedly inhibits NA release. These findings provide further support for the differential modulation of NA and ATP release.
机译:class =“ enumerated” style =“ list-style-type:decimal”> <!-list-behavior =枚举前缀-word = mark-type = decimal max-label-size = 0-> 在鼠尾动脉中已研究了阻断α2-肾上腺素受体对神经节后交感神经释放去甲肾上腺素(NA)和5'-三磷酸腺苷(ATP)释放的影响。使用连续安培法测量NA释放,并使用细胞内记录的兴奋性连接电位(ejp's)测量ATP释放。 应用α2-肾上腺素受体拮抗剂伊达唑烷(1μM),可增加振幅在10和10 Hz的频率下由10个刺激的火车诱发的NA诱导的氧化电流的变化。 在培养基深处的细胞中,伊达唑烷(1μM)对火车诱发的ejp的振幅没有影响1和10 Hz的10个刺激在接近外膜-内侧边界的细胞中,伊达唑烷在1 Hz的10个刺激序列结束时引起ejp诱发的振幅略有增加。 在用神经元NA摄取预处理的组织中抑制剂去甲基异丙胺(0.3μM),咪唑烷(1μM)显着增加了培养基中深层细胞中ejp的幅度。 α2-肾上腺素受体激动剂可乐定(0.5μM)产生了类似的减少在NA诱导的氧化电流和ejp的振幅中都受到1 Hz的10个刺激的影响。可乐定的这些作用可通过随后添加偶氮唑烷(1μM)来逆转。 可乐定激活结前α2-肾上腺素受体可将NA和ATP的释放抑制到相似的程度。相反,内源性释放的NA更明显地抑制NA的释放。这些发现为NA和ATP释放的差异调节提供了进一步的支持。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号